VYNE Therapeutics Inc — Rendiconto Finanziario (NASDAQ:VYNE) | MetaTrader

Apri il grafico completo

Notizie

VYNE Therapeutics si fonde con Yarrow Bioscience in un accordo da 200 milioni di dollari

VYNE Therapeutics to merge with Yarrow Bioscience in $200 million deal

VYNE Therapeutics Inc. (VYNE) Yarrow Bioscience, Inc. - M&A Call Prepared Remarks Transcript

Le azioni di Vyne Therapeutics volano dopo la fusione con Yarrow Bioscience

Vyne Therapeutics stock soars after merger with Yarrow Bioscience

VYNE e Yarrow Bioscience si fondono in una transazione interamente in azioni

VYNE and Yarrow Bioscience to merge in all-stock transaction

Crude Oil Rises Over 1%; General Mills Earnings Top Views - DBV Technologies (NASDAQ:DBVT), General Mills (NYSE:GIS)

Dow Jumps 150 Points; Jabil Posts Upbeat Earnings - Aditxt (NASDAQ:ADTX), Agape ATP (NASDAQ:ATPC)

VYNE Therapeutics Inc. (VYNE) Reports Q3 Loss, Tops Revenue Estimates

VYNE Therapeutics Inc. (VYNE) Reports Q2 Loss, Lags Revenue Estimates

Metagenomi (MGX) Reports Q2 Loss, Tops Revenue Estimates